Computerized image analysis developer VirtualScopics has released version 2.0 of its software platform for the use of imaging in clinical trials.
The new platform provides tools required by the U.S. Food and Drug Administration (FDA) for managing international imaging sites, according to the Rochester, NY-based firm. It also includes a new image analysis automation system, improved traceability, enhanced data management tools, and real-time detailed reports, VirtualScopics said.
By AuntMinnie.com staff writers
May 21, 2007
Related Reading
VirtualScopics reports record contracts, January 8, 2007
VirtualScopics gets patent, November 30, 2006
VirtualScopics shows Q2 sales increase, August 10, 2006
VirtualScopics begins Nasdaq trading, May 31, 2006
VirtualScopics signs Markin, April 28, 2006
Copyright © 2007 AuntMinnie.com